Results 211 to 220 of about 82,921 (264)
Some of the next articles are maybe not open access.
Nursing Standard, 2004
Hodgkin's lymphoma is a malignant disease of the lymphatic system. This article gives an overview of the disease process and the classification and staging of Hodgkin's lymphoma. The nursing care and psychological support of these patients during radiotherapy and chemotherapy treatment are also discussed.
Sylvia, Cole, Kathleen, Dunne
openaire +2 more sources
Hodgkin's lymphoma is a malignant disease of the lymphatic system. This article gives an overview of the disease process and the classification and staging of Hodgkin's lymphoma. The nursing care and psychological support of these patients during radiotherapy and chemotherapy treatment are also discussed.
Sylvia, Cole, Kathleen, Dunne
openaire +2 more sources
The Lancet, 2003
Hodgkin's lymphoma was first described in 1832, but the nature of the pathognomic Reed-Sternberg cell, on which diagnosis of the disease is based, has only been elucidated in the past few years. Radiotherapy has been used to treat localised disease since the 1940s, and in the 1960s, effective combination chemotherapy regimens were introduced for ...
Lynny, Yung, David, Linch
openaire +2 more sources
Hodgkin's lymphoma was first described in 1832, but the nature of the pathognomic Reed-Sternberg cell, on which diagnosis of the disease is based, has only been elucidated in the past few years. Radiotherapy has been used to treat localised disease since the 1940s, and in the 1960s, effective combination chemotherapy regimens were introduced for ...
Lynny, Yung, David, Linch
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 2013
Hodgkin lymphoma (HL) is a curable malignancy which shows a bimodal curve in incidence in economically developed countries; there is a putative association with Epstein-Barr virus. The WHO 2008 classification schema recognises two histological types of HL: the nodular lymphocyte predominant and the "classic" HL.
GOBBI, PAOLO +3 more
openaire +3 more sources
Hodgkin lymphoma (HL) is a curable malignancy which shows a bimodal curve in incidence in economically developed countries; there is a putative association with Epstein-Barr virus. The WHO 2008 classification schema recognises two histological types of HL: the nodular lymphocyte predominant and the "classic" HL.
GOBBI, PAOLO +3 more
openaire +3 more sources
Current Problems in Cancer, 2006
An estimated 8,490 new cases of Hodgkin’s lymphoma were diagnosed in the USA in 2010. Reed–Sternberg cells are the malignant cells in classical Hodgkin’s lymphoma (CD15+, CD30+, and CD45−). In nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL), these cells express B-cell markers (CD20+, CD79a+, and CD45+) and are CD15− and CD30 ...
Richard W, Tsang +2 more
openaire +2 more sources
An estimated 8,490 new cases of Hodgkin’s lymphoma were diagnosed in the USA in 2010. Reed–Sternberg cells are the malignant cells in classical Hodgkin’s lymphoma (CD15+, CD30+, and CD45−). In nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL), these cells express B-cell markers (CD20+, CD79a+, and CD45+) and are CD15− and CD30 ...
Richard W, Tsang +2 more
openaire +2 more sources
Critical Reviews in Oncogenesis, 2013
Anemia is a frequent finding of Hodgkin's lymphoma (HL) diagnosis. It is usually mild, with hemoglobin levels between 10 and 12 g/dl; it is rarely (
Hohaus, S +4 more
openaire +4 more sources
Anemia is a frequent finding of Hodgkin's lymphoma (HL) diagnosis. It is usually mild, with hemoglobin levels between 10 and 12 g/dl; it is rarely (
Hohaus, S +4 more
openaire +4 more sources
Hematological Oncology, 2023
Abstract Classic Hodgkin lymphoma (HL) is rare disease, with an incidence of approximately 85,000 patients globally per year and a predilection for adolescents and young adults (ages 15–39). Since the introduction of combination chemotherapy in the 1960's and radiation dating back to the early 1900's, therapeutic options and by ...
Justine Kahn +7 more
openaire +2 more sources
Abstract Classic Hodgkin lymphoma (HL) is rare disease, with an incidence of approximately 85,000 patients globally per year and a predilection for adolescents and young adults (ages 15–39). Since the introduction of combination chemotherapy in the 1960's and radiation dating back to the early 1900's, therapeutic options and by ...
Justine Kahn +7 more
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2009
Hodgkin disease was first described more than 175 years ago. Clinically and histomorphologically, the features of Hodgkin lymphoma are unusual for a lymphoma or for other malignancies. The incidence of Hodgkin lymphoma is estimated to be 7400 new cases per year in the United States, resulting in an age-adjusted yearly rate of 2.7 per 100,000 per year ...
openaire +2 more sources
Hodgkin disease was first described more than 175 years ago. Clinically and histomorphologically, the features of Hodgkin lymphoma are unusual for a lymphoma or for other malignancies. The incidence of Hodgkin lymphoma is estimated to be 7400 new cases per year in the United States, resulting in an age-adjusted yearly rate of 2.7 per 100,000 per year ...
openaire +2 more sources
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Current Hematologic Malignancy Reports, 2018The ligation of PD-1 with PD-L1 activates a critical immune checkpoint leading to T cell dysfunction, exhaustion, and tolerance. Anti-PD-1 or anti-PD-L1 monoclonal antibodies can reverse the immune checkpoint, releasing the brake on T cell responses.
Bei, Hu, Ryan, Jacobs, Nilanjan, Ghosh
openaire +2 more sources
The Lymphomas: Hodgkin's Disease and Non-Hodgkin's Lymphomas
American Pharmacy, 1991This review presents an overview of a heterogeneous group of disorders that fall under the general heading of lymphomas. Many specific subtypes and presentations exist; their presentations, treatments, and prognoses vary greatly. Patients with lymphomas are generally treated with external beam radiation therapy, chemotherapy, or a combination of these ...
openaire +2 more sources